Robert A. Bradway

Chairman and CEO of Amgen, describing the company's long-acting obesity candidate (Meritide), rare-disease business performance, and the benefits of Repatha for lowering LDL and reducing cardiovascular risk.

Best podcasts with Robert A. Bradway

Ranked by the Snipd community

Jan 14, 2026 • 44min

Mad Money w/ Jim Cramer 1/13/26

In this episode, Jim Cramer sits down with several industry leaders. Dr. Vass Nairosif, CEO of Novartis, shares insights on portfolio simplification and the future of radioligand therapy. Robert Bradway from Amgen discusses his company's innovative obesity drug, highlighting long-term efficacy. Dr. Leonard Schleifer of Regeneron talks about groundbreaking treatments like Dupixent and their advancements in cardiovascular risk. Jason Holler of Cardinal Health explores operational improvements and specialty distribution, emphasizing a strong financial outlook.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app